These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 17006721

  • 1. Oral contraceptive use and risk of breast carcinoma in situ (United States).
    Gill JK, Press MF, Patel AV, Bernstein L.
    Cancer Causes Control; 2006 Nov; 17(9):1155-62. PubMed ID: 17006721
    [Abstract] [Full Text] [Related]

  • 2. Oral contraceptives and breast cancer risk among younger women.
    Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, Stanford JL, Coates RJ, Gammon MD, Hanson L, Hoover RN.
    J Natl Cancer Inst; 1995 Jun 07; 87(11):827-35. PubMed ID: 7791232
    [Abstract] [Full Text] [Related]

  • 3. Oral contraceptive use and risk of breast carcinoma in situ.
    Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA.
    Cancer Epidemiol Biomarkers Prev; 2007 Nov 07; 16(11):2262-8. PubMed ID: 18006914
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk of breast cancer associated with short-term use of oral contraceptives.
    Folger SG, Marchbanks PA, McDonald JA, Bernstein L, Ursin G, Berlin JA, Daling JR, Norman SA, Strom BL, Weiss LK, Simon MS, Burkman RT, Malone KE, Spirtas R.
    Cancer Causes Control; 2007 Mar 07; 18(2):189-98. PubMed ID: 17216547
    [Abstract] [Full Text] [Related]

  • 6. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
    Lee E, Ma H, McKean-Cowdin R, Van Den Berg D, Bernstein L, Henderson BE, Ursin G.
    Cancer Epidemiol Biomarkers Prev; 2008 Nov 07; 17(11):3170-8. PubMed ID: 18990759
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for in situ breast cancer.
    Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK.
    Cancer Epidemiol Biomarkers Prev; 1996 Dec 07; 5(12):961-5. PubMed ID: 8959317
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports.
    Hawley W, Nuovo J, DeNeef CP, Carter P.
    J Am Board Fam Pract; 1993 Dec 07; 6(2):123-35. PubMed ID: 8452064
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cigarette smoking and risk of breast carcinoma in situ.
    Trentham-Dietz A, Nichols HB, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA.
    Epidemiology; 2007 Sep 07; 18(5):629-38. PubMed ID: 17700252
    [Abstract] [Full Text] [Related]

  • 13. Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.
    Kotsopoulos J, Lubinski J, Moller P, Lynch HT, Singer CF, Eng C, Neuhausen SL, Karlan B, Kim-Sing C, Huzarski T, Gronwald J, McCuaig J, Senter L, Tung N, Ghadirian P, Eisen A, Gilchrist D, Blum JL, Zakalik D, Pal T, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group.
    Breast Cancer Res Treat; 2014 Feb 07; 143(3):579-86. PubMed ID: 24458845
    [Abstract] [Full Text] [Related]

  • 14. The association between oral contraceptive use and lobular and ductal breast cancer in young women.
    Nyante SJ, Gammon MD, Malone KE, Daling JR, Brinton LA.
    Int J Cancer; 2008 Feb 15; 122(4):936-41. PubMed ID: 17957781
    [Abstract] [Full Text] [Related]

  • 15. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD.
    Cancer Epidemiol Biomarkers Prev; 1999 May 15; 8(5):413-9. PubMed ID: 10350436
    [Abstract] [Full Text] [Related]

  • 16. Lifetime recreational exercise activity and risk of breast carcinoma in situ.
    Patel AV, Press MF, Meeske K, Calle EE, Bernstein L.
    Cancer; 2003 Nov 15; 98(10):2161-9. PubMed ID: 14601085
    [Abstract] [Full Text] [Related]

  • 17. Oral contraceptive use and risk of breast cancer in middle-aged women.
    Rossing MA, Stanford JL, Weiss NS, Habel LA.
    Am J Epidemiol; 1996 Jul 15; 144(2):161-4. PubMed ID: 8678047
    [Abstract] [Full Text] [Related]

  • 18. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT.
    Am J Obstet Gynecol; 2004 Sep 15; 191(3):733-40. PubMed ID: 15467532
    [Abstract] [Full Text] [Related]

  • 19. Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group.
    Figueiredo JC, Bernstein L, Capanu M, Malone KE, Lynch CF, Anton-Culver H, Stovall M, Bertelsen L, Haile RW, Bernstein JL, WECARE Study Group.
    J Clin Oncol; 2008 Mar 20; 26(9):1411-8. PubMed ID: 18250348
    [Abstract] [Full Text] [Related]

  • 20. Do thyroid disorders increase the risk of breast cancer?
    Simon MS, Tang MT, Bernstein L, Norman SA, Weiss L, Burkman RT, Daling JR, Deapen D, Folger SG, Malone K, Marchbanks PA, McDonald JA, Strom BL, Wilson HG, Spirtas R.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec 20; 11(12):1574-8. PubMed ID: 12496046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.